Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1623 1673 1693 4100
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18289431 | COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION | Non-Final OA | Abbott Molecular Inc. |
| 18043009 | METHODS FOR THE PREVENTION OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS | Final Rejection | Beren Therapeutics P.B.C. |
| 18023325 | METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE WITH CYCLODEXTRINS | Final Rejection | Beren Therapeutics P.B.C. |
| 18027763 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING AUTOIMMUNE DISORDERS | Non-Final OA | The Regents of the University of Michigan |
| 18633908 | THERAPEUTIC COMPOUNDS | Non-Final OA | Regents of the University of Minnesota |
| 18291956 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | Non-Final OA | L'OREAL |
| 18575623 | POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy